Evidence map›Paper›PMID 17003455›Full record

ArticleInvestigative ophthalmology & visual science2006

Genomic rearrangements of the PRPF31 gene account for 2.5% of autosomal dominant retinitis pigmentosa.

Lori S Sullivan, Sara J Bowne, C Robyn Seaman, Susan H Blanton, Richard A Lewis, John R Heckenlively, David G Birch, Dianna Hughbanks-Wheaton, Stephen P Daiger

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05573984 (A Natural History and Outcome Measure Discovery Study of PRPF31 Mutation-Associated Retinal Dystrophy), which is not on this map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05573984 active not recruitingnot on this mapstarted 2022, after this paper: background citation

A Natural History and Outcome Measure Discovery Study of PRPF31 Mutation-Associated Retinal Dystrophy

TypeobservationalSponsorPYC TherapeuticsRan2022 to 2026Enrolled50ConditionsRetinitis Pigmentosa, Eye Diseases, Hereditary, Retinal Dystrophies, Retinal Dystrophy Rod
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 81 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Alternative RNA Splicing in the Retina: Insights and Perspectives.Cold Spring Harbor perspectives in medicine · 2023
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Copy-number variation is an important contributor to the genetic causality of inherited retinal degenerations.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Lori S SullivanHuman Genetics Center, The University of Texas Health Science Center at Houston, TX 77030, USA. lori.s.sullivan@uth.tmc.edu
Sara J Bowne
C Robyn Seaman
Susan H Blanton
Richard A Lewis
John R Heckenlively
David G Birch
Dianna Hughbanks-Wheaton
Stephen P Daiger
Center for Human Genetics · USRetina Foundation of the Southwest · USBaylor College of Medicine · USUniversity of Michigan–Ann Arbor · USUniversity of Virginia · US

Funding

DNA LINKAGE STUDIES OF DEGENERATIVE RETINAL DISEASESR01EY007142 · NEI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DAIGER, STEPHEN P · 1989 to 2017
$4.1M
RETINAL PATHOPHYSIOLOGY OF INFANTS AND ADULTSR01EY005235 · NEI · RETINA FOUNDATION OF THE SOUTHWEST · PI BIRCH, DAVID G · 1985 to 2005
$1.6M
NEI NIH HHS R01 EY005235NEI NIH HHS R01 EY007142
6 · The paper itself

Abstract

purposeTo determine whether genomic rearrangements in the PRPF31 (RP11) gene are a frequent cause of autosomal dominant retinitis pigmentosa (adRP) in a cohort of patients with adRP.

methodsIn a cohort of 200 families with adRP, disease-causing mutations have previously been identified in 107 families. To determine the cause of disease in the remaining families, linkage testing was performed with markers for 13 known adRP loci. In a large American family, evidence was found of linkage to the PRPF31 gene, although DNA sequencing revealed no mutations. SNP testing throughout the genomic region was used to determine whether any part of the gene was deleted. Aberrant segregation of a SNP near exon 1 was observed, leading to the testing of additional SNPs in the region. After identifying an insertion-deletion mutation, the remaining 92 families were screened for genomic rearrangements in PRPF31 with multiplex ligation-dependent probe amplification (MLPA).

resultsFive unique rearrangements were identified in the 93 families tested. In the large family used for linkage exclusion testing, an insertion-deletion was found that disrupts exon 1. The other four mutations identified in the cohort were deletions, ranging from 5 kb to greater than 45 kb. Two of the large deletions encompass all PRPF31 as well as several adjacent genes. The two smaller deletions involve either 5 or 10 completely deleted exons.

conclusionsIn an earlier long-term study of 200 families with adRP, disease-causing mutations were identified in 53% of the families. Mutation-testing by sequencing missed large-scale genomic rearrangements such as insertions or deletions. MLPA was used to identify genomic rearrangements in PRPF31 in five families, suggesting a frequency of approximately 2.5%. Mutations in PRPF31 now account for 8% of this adRP cohort.

Indexed as

Gene DeletionGene RearrangementMutationAdolescentAdultDNA Mutational AnalysisDNA ProbesEye ProteinsFemaleGenes, DominantGenetic LinkageGenome, HumanHumansMaleMiddle AgedNucleic Acid Amplification TechniquesDNA ProbesEye ProteinsPRPF31 protein, human

Identifiers

PMID17003455
PMCPMC2778205
OpenAlexW2052585139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.